Owens & Minor Debt to Equity Ratio 2010-2025 | OMI
Current and historical debt to equity ratio values for Owens & Minor (OMI) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Owens & Minor debt/equity for the three months ending March 31, 2025 was 3.32.
| Owens & Minor Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2025-03-31 | $4.29B | $0.57B | 7.51 |
| 2024-12-31 | $4.07B | $0.59B | 6.94 |
| 2024-09-30 | $4.21B | $0.88B | 4.81 |
| 2024-06-30 | $4.44B | $0.86B | 5.16 |
| 2024-03-31 | $4.31B | $0.90B | 4.82 |
| 2023-12-31 | $4.17B | $0.92B | 4.51 |
| 2023-09-30 | $4.24B | $0.89B | 4.78 |
| 2023-06-30 | $4.39B | $0.90B | 4.90 |
| 2023-03-31 | $4.39B | $0.92B | 4.74 |
| 2022-12-31 | $4.44B | $0.95B | 4.70 |
| 2022-09-30 | $4.57B | $0.97B | 4.73 |
| 2022-06-30 | $4.60B | $0.96B | 4.80 |
| 2022-03-31 | $4.76B | $0.95B | 5.02 |
| 2021-12-31 | $2.60B | $0.94B | 2.77 |
| 2021-09-30 | $2.70B | $0.89B | 3.04 |
| 2021-06-30 | $2.74B | $0.85B | 3.24 |
| 2021-03-31 | $2.61B | $0.79B | 3.31 |
| 2020-12-31 | $2.62B | $0.71B | 3.69 |
| 2020-09-30 | $2.85B | $0.45B | 6.31 |
| 2020-06-30 | $2.74B | $0.40B | 6.94 |
| 2020-03-31 | $3.30B | $0.42B | 7.92 |
| 2019-12-31 | $3.18B | $0.46B | 6.88 |
| 2019-09-30 | $3.20B | $0.49B | 6.51 |
| 2019-06-30 | $3.40B | $0.50B | 6.84 |
| 2019-03-31 | $3.38B | $0.50B | 6.74 |
| 2018-12-31 | $3.26B | $0.52B | 6.28 |
| 2018-09-30 | $3.24B | $0.79B | 4.09 |
| 2018-06-30 | $3.24B | $0.80B | 4.04 |
| 2018-03-31 | $2.37B | $1.02B | 2.33 |
| 2017-12-31 | $2.36B | $1.02B | 2.33 |
| 2017-09-30 | $2.33B | $1.00B | 2.32 |
| 2017-06-30 | $1.80B | $0.99B | 1.81 |
| 2017-03-31 | $1.73B | $0.97B | 1.78 |
| 2016-12-31 | $1.76B | $0.96B | 1.83 |
| 2016-09-30 | $1.81B | $0.99B | 1.83 |
| 2016-06-30 | $1.76B | $1.00B | 1.77 |
| 2016-03-31 | $1.79B | $1.01B | 1.78 |
| 2015-12-31 | $1.78B | $0.99B | 1.79 |
| 2015-09-30 | $1.77B | $0.99B | 1.79 |
| 2015-06-30 | $1.82B | $0.98B | 1.86 |
| 2015-03-31 | $1.73B | $0.97B | 1.79 |
| 2014-12-31 | $1.75B | $0.99B | 1.76 |
| 2014-09-30 | $1.94B | $1.01B | 1.92 |
| 2014-06-30 | $1.33B | $1.03B | 1.29 |
| 2014-03-31 | $1.34B | $1.03B | 1.29 |
| 2013-12-31 | $1.30B | $1.03B | 1.27 |
| 2013-09-30 | $1.34B | $1.01B | 1.33 |
| 2013-06-30 | $1.39B | $0.99B | 1.40 |
| 2013-03-31 | $1.34B | $0.98B | 1.37 |
| 2012-12-31 | $1.24B | $0.97B | 1.27 |
| 2012-09-30 | $1.26B | $0.96B | 1.31 |
| 2012-06-30 | $1.01B | $0.95B | 1.06 |
| 2012-03-31 | $0.99B | $0.94B | 1.06 |
| 2011-12-31 | $1.03B | $0.92B | 1.12 |
| 2011-09-30 | $1.04B | $0.91B | 1.15 |
| 2011-06-30 | $1.01B | $0.90B | 1.13 |
| 2011-03-31 | $1.03B | $0.88B | 1.17 |
| 2010-12-31 | $0.97B | $0.86B | 1.13 |
| 2010-09-30 | $1.00B | $0.84B | 1.20 |
| 2010-06-30 | $0.99B | $0.82B | 1.21 |
| 2010-03-31 | $0.96B | $0.79B | 1.21 |
| 2009-12-31 | $0.98B | $0.77B | 1.27 |
| 2009-09-30 | $0.95B | $0.75B | 1.28 |
| 2009-06-30 | $0.98B | $0.71B | 1.37 |
| 2009-03-31 | $0.99B | $0.70B | 1.42 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.532B | $10.701B |
| Owens & Minor, Inc. is a global healthcare solutions company dedicated to Connecting the World of Medical Products to the Point of CareSM by providing vital supply chain services to healthcare providers and manufacturers of healthcare products. Owens & Minor provides logistics services across the spectrum of medical products from disposable medical supplies to devices and implants. With logistics platforms strategically located in the United States and Europe, Owens & Minor serves markets where three quarters of global healthcare spending occurs. Owens & Minor's customers span the healthcare market from independent hospitals to large integrated healthcare networks, as well as group purchasing organizations, healthcare products manufacturers, the federal government, and healthcare patients at home through the Byram Healthcare subsidiary. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $228.788B | 27.51 |
| Boston Scientific (BSX) | United States | $154.602B | 38.70 |
| Stryker (SYK) | United States | $144.385B | 30.19 |
| EssilorLuxottica (ESLOY) | France | $135.514B | 0.00 |
| Medtronic (MDT) | Ireland | $103.771B | 14.71 |
| Haleon (HLN) | United Kingdom | $49.845B | 28.36 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.977B | 0.00 |
| ResMed (RMD) | United States | $35.996B | 27.04 |
| GE HealthCare Technologies (GEHC) | United States | $31.796B | 15.10 |
| Agilent Technologies (A) | United States | $31.270B | 20.66 |
| Terumo (TRUMY) | Japan | $27.864B | 36.19 |
| Insulet (PODD) | United States | $22.590B | 88.67 |
| Koninklijke Philips (PHG) | Netherlands | $21.684B | 15.59 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.137B | 11.65 |
| Baxter (BAX) | United States | $15.534B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.438B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.637B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.181B | 21.51 |
| Lantheus Holdings (LNTH) | United States | $5.172B | 13.05 |
| Prestige Consumer Healthcare (PBH) | United States | $4.201B | 18.77 |
| Perrigo (PRGO) | Ireland | $3.629B | 9.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.218B | 23.73 |
| Haemonetics (HAE) | United States | $3.178B | 14.48 |
| Envista Holdings (NVST) | United States | $2.859B | 23.76 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.788B | 39.96 |
| AtriCure (ATRC) | United States | $1.624B | 0.00 |
| Neogen (NEOG) | United States | $1.343B | 17.19 |
| Acuren (TIC) | United States | $1.288B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.206B | 12.25 |
| Green Thumb Industries (GTBIF) | United States | $1.175B | 26.43 |
| Kestra Medical Technologies (KMTS) | United States | $1.145B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.050B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.933B | 11.93 |
| InMode (INMD) | Israel | $0.906B | 9.13 |
| CeriBell (CBLL) | United States | $0.624B | 0.00 |
| Evolus (EOLS) | United States | $0.616B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.584B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.558B | 0.00 |
| Valneva SE (VALN) | France | $0.529B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.496B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.450B | 0.00 |
| Surmodics (SRDX) | United States | $0.417B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.355B | 0.00 |
| SNDL (SNDL) | Canada | $0.344B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.336B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.318B | 11.71 |
| Aurora Cannabis (ACB) | Canada | $0.309B | 54.90 |
| Sanara MedTech (SMTI) | United States | $0.275B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.258B | 21.73 |
| Sanuwave Health (SNWV) | United States | $0.247B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.244B | 0.00 |
| Cerus (CERS) | United States | $0.239B | 0.00 |
| ZimVie (ZIMV) | United States | $0.233B | 10.57 |
| Biote (BTMD) | United States | $0.205B | 5.77 |
| Brainsway (BWAY) | Israel | $0.197B | 52.15 |
| OraSure Technologies (OSUR) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Omeros (OMER) | United States | $0.189B | 0.00 |
| Quanterix (QTRX) | United States | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.183B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.174B | 14.20 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.117B | 0.00 |
| Agape ATP (ATPC) | $0.112B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.087B | 11.17 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Veru (VERU) | United States | $0.072B | 0.00 |
| InterCure (INCR) | Israel | $0.071B | 0.00 |
| Zynex (ZYXI) | United States | $0.070B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| Apyx Medical (APYX) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| United Health Products (UEEC) | United States | $0.051B | 0.00 |
| Modular Medical (MODD) | United States | $0.045B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Rockwell Medical (RMTI) | United States | $0.034B | 0.00 |
| Safety Shot (SHOT) | United States | $0.028B | 0.00 |
| Nephros (NEPH) | United States | $0.028B | 37.57 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |